ID: ALA3400959

Max Phase: Preclinical

Molecular Formula: C29H36Cl2N6O3

Molecular Weight: 551.09

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CCCOC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C.Cl

Standard InChI:  InChI=1S/C29H35ClN6O3.ClH/c1-33(2)13-7-15-39-28(38)19-11-12-24-22(16-19)25-26(27(37)34(24)3)36(17-20-8-4-5-10-23(20)30)29(32-25)35-14-6-9-21(31)18-35;/h4-5,8,10-12,16,21H,6-7,9,13-15,17-18,31H2,1-3H3;1H/t21-;/m1./s1

Standard InChI Key:  WMRALVUYXKVVQN-ZMBIFBSDSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serum 604 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 551.09Molecular Weight (Monoisotopic): 550.2459AlogP: 3.63#Rotatable Bonds: 8
Polar Surface Area: 98.62Molecular Species: BASEHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.01CX LogP: 3.89CX LogD: -0.52
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.26Np Likeness Score: -1.23

References

1. Ikuma Y, Hochigai H, Kimura H, Nunami N, Kobayashi T, Uchiyama K, Umezome T, Sakurai Y, Sawada N, Tadano J, Sugaru E, Ono M, Hirose Y, Nakahira H..  (2015)  Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: use of a carboxylate prodrug to improve bioavailability.,  23  (4): [PMID:25596166] [10.1016/j.bmc.2014.12.051]

Source